Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5051
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$107M
| $1.38M | ﹤0.01% |
47,004
-4,632
| -9% | -$128K |
|
5052
First Trust Germany AlphaDEX Fund
FGM
$98.5M
| $1.38M | ﹤0.01% |
34,008
+23,867
| +235% | +$882K |
|
5053
Pebblebrook Hotel Trust
PEB
$2.06B
| $1.38M | ﹤0.01% |
101,340
+68,891
| +212% | +$853K |
|
5054
CALL
Purple Innovation
PRPL
$29.7M
| $1.38M | ﹤0.01% |
+3,076
| New | +$970K |
|
5055
CALL
Equinox Gold
EQX
$13.5B
| $1.38M | ﹤0.01% |
+123,300
| New | +$1.1M |
|
5056
StoneCo
STNE
$2.32B
| $1.38M | ﹤0.01% |
35,678
-160,465
| -82% | -$4.68M |
|
5057
Hyster-Yale Materials Handling
HY
$618M
| $1.38M | ﹤0.01% |
35,644
+23,904
| +204% | +$891K |
|
5058
CALL
iShares Russell Mid-Cap ETF
IWR
$58.4B
| $1.38M | ﹤0.01% |
25,700
+14,000
| +120% | +$702K |
|
|
AZPN
5059
PUT
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $1.38M | ﹤0.01% |
13,300
-1,300
| -9% | -$135K |
|
5060
iShares MSCI Poland ETF
EPOL
$822M
| $1.38M | ﹤0.01% |
+82,893
| New | +$1.29M |
|
5061
iShares 10-20 Year Treasury Bond ETF
TLH
$10.8B
| $1.38M | ﹤0.01% |
8,227
-6,143
| -43% | -$1.03M |
|
5062
ALPS Disruptive Technologies ETF
DTEC
$77.4M
| $1.38M | ﹤0.01% |
39,766
-89,748
| -69% | -$2.82M |
|
5063
PUT
Virtu Financial
VIRT
$5.3B
| $1.38M | ﹤0.01% |
58,300
-5,700
| -9% | -$133K |
|
5064
CALL
Encompass Health
EHC
$12.2B
| $1.38M | ﹤0.01% |
27,905
-38,465
| -58% | -$2.08M |
|
5065
iShares MSCI India Small-Cap ETF
SMIN
$771M
| $1.38M | ﹤0.01% |
47,077
-7,666
| -14% | -$200K |
|
5066
iShares Global Materials ETF
MXI
$356M
| $1.37M | ﹤0.01% |
21,932
-43,643
| -67% | -$2.51M |
|
5067
PUT
NeoGenomics
NEO
$2.05B
| $1.37M | ﹤0.01% |
44,300
-62,000
| -58% | -$1.72M |
|
5068
PUT
Protolabs
PRLB
$2.2B
| $1.37M | ﹤0.01% |
12,200
+500
| +4% | +$51.3K |
|
|
LVUS
5069
DELISTED
Hartford Multifactor Low Volatility US Equity ETF
LVUS
| $1.37M | ﹤0.01% |
49,653
+27,312
| +122% | +$732K |
|
5070
Tactile Systems Technology
TCMD
$548M
| $1.37M | ﹤0.01% |
33,079
-164,144
| -83% | -$7.69M |
|
5071
PUT
NCR Voyix
VYX
$1.13B
| $1.37M | ﹤0.01% |
128,933
+66,667
| +107% | +$764K |
|
5072
PUT
Brookfield
BN
$107B
| $1.37M | ﹤0.01% |
77,729
-77,402
| -50% | -$1.36M |
|
5073
PUT
Bank of Hawaii
BOH
$3.17B
| $1.37M | ﹤0.01% |
22,300
+12,400
| +125% | +$766K |
|
5074
PUT
Ultragenyx Pharmaceutical
RARE
$2.61B
| $1.37M | ﹤0.01% |
17,500
-9,600
| -35% | -$635K |
|
5075
First Trust Utilities AlphaDEX Fund
FXU
$835M
| $1.37M | ﹤0.01% |
53,059
-10,659
| -17% | -$280K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.